BXN-70492-15983
2 vaccinations
2 coded responses
3 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 837 / ID
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2020-12-28
Survey response — day 0, dose 1MedDRA: Hot flush — Feeling: Good · FeverFree text: Feel like I'm having hot flashes about 8 hours after 1st doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-29
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-07-20
Survey response — 6 months, dose 2MedDRA: Emergency care, Impaired work ability, Office visit, Skin discolouration — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: Discoloration of toes starting within 2 weeks after 1st immunization, 3 separate episodes all starting after vaccine, last episode the worst -Within 5 weeks post 2nd dose - apple area next similar to COVID toes, no COVID. Echo and CT angiogram · Healthcare visit (other): ER after initial discoloration, 2 Dermatology visits, 2-3 Primary care visits, Echo and CT angiogram outpatient Appts, 5 weeks off work FMLA, 4 consults with Rheumatologist and awaiting appointment with Cardiovascular doctorMedDRA releases: 2024-11 · check-in free text available
-
2021-07-20
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-26
-
2021-08-03
Call successfulReported to VAERS voluntarily prior to GDIT contact
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Feel like I'm having hot flashes about 8 hours after 1st dose
Release 9 — 6 months, dose 2
Symptoms: Discoloration of toes starting within 2 weeks after 1st immunization, 3 separate episodes all starting after vaccine, last episode the worst -Within 5 weeks post 2nd dose - apple area next similar to COVID toes, no COVID. Echo and CT angiogram
Healthcare visit (other): ER after initial discoloration, 2 Dermatology visits, 2-3 Primary care visits, Echo and CT angiogram outpatient Appts, 5 weeks off work FMLA, 4 consults with Rheumatologist and awaiting appointment with Cardiovascular doctor
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | · | · | ✓ |
| HCVO | Impaired work ability | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | Skin discolouration | · | · | ✓ |
| SD | Skin discolouration | · | · | ✓ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release